Cite
APA Citation
Xu, B., Zhang, Q., Sun, T., Li, W., Teng, Y., Hu, X., Bondarenko, I., Adamchuk, H., Li, Y., Shan, B., Cheng, J., Peng, T., Wang, X., Chen, Y., Jiang, W., Liu, S., Zhang, X., Liu, E., LUK, A., & Wang, Q. (n.d.). lBA6First China-manufactured trastuzumab biosimilar HLX02 global phase III trial met primary endpoint in breast cancer. Annals of oncology, 30, . http://access.bl.uk/ark:/81055/vdc_100098040444.0x000037